PHIO PHARMACEUTICALS CORP. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d7218fd3-775a-4fcb-a970-4f7e206e9fb4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-9.2M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-007078 |
| FY 2024 | $-7.4M | 2024-01-01 – 2024-12-31 | evidence 0001683168-25-002134 |
| FY 2023 | $-10.8M | 2023-01-01 – 2023-12-31 | evidence 0001683168-24-002021 |
| FY 2022 | $-11.5M | 2022-01-01 – 2022-12-31 | evidence 0001683168-23-001678 |
| FY 2021 | $-13.5M | 2021-01-01 – 2021-12-31 | evidence 0001683168-22-001833 |
| FY 2020 | $-8.8M | 2020-01-01 – 2020-12-31 | evidence 0001683168-21-001062 |
| FY 2019 | $-9.0M | 2019-01-01 – 2019-12-31 | evidence 0001683168-20-000969 |
| FY 2018 | $-7.4M | 2018-01-01 – 2018-12-31 | evidence 0001683168-19-000795 |
| FY 2017 | $-14.1M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-096053 |
| FY 2016 | $-9.0M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-102730 |
| FY 2015 | $-10.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-523721 |
| FY 2014 | $-8.8M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-110334 |
| FY 2013 | $-20.9M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-121519 |
| FY 2012 | $-95.9M | 2003-01-01 – 2012-12-31 | evidence 0001193125-13-133515 |
| FY 2011 | $-12.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-133515 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PHIO PHARMACEUTICALS CORP. — all facts · Revenue · Net Income